A checkup on weight-loss drugs

A checkup on weight-loss drugs

Up next

Delhi protests, Trump's Russia diesel deal and Panama quake

A loud blast at Riyadh airport has prompted evacuations. India's capital is under lockdown after authorities detained a youth protest leader ahead of major anti-government rally. President Donald Trump has praised Vladimir Putin are striking a deal to return Russian diesel to glo ...  Show more

US execution livestream, ICC sanctions, ICE defends NYC shooting (Updated)

The US says it will livestream the firing squad execution of the Fort Hood shooter. The Trump administration sanctions the International Criminal Court hours after a former ICC judge wins the 2026 Nobel Peace Prize. ICE defends its officers after a shooting in New York City. And ...  Show more

Recommended Episodes

The obesity drug craze is entering its next phase
Viewsroom

Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ...  Show more

One Thing: Weight Loss Drugs: Trend or Treatment?
CNN 5 Things

A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ...  Show more

The Weight-Loss Drug Revolution, Part 1: Why These Drugs Work So Well
Plain English with Derek Thompson

Today’s podcast is about the weight-loss drug revolution—which I believe might be one of the most important stories in the world right now. Despite all the attention weight-loss drugs are receiving, it’s possible that they might soon affect the world even more than we realize as ...  Show more

068 | The weight is over: How GLP-1 treatments are reshaping pharma and beyond
Tomorrow – A podcast by Allianz Research

Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ...  Show more